Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Atrial Fibrillation, Persistent clinical trials
1 of 4 indexed Atrial Fibrillation, Persistent trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Atrial Fibrillation, Persistent: 4 US clinical trials tracked, 1 recruiting.
Atrial Fibrillation, Persistent is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Ablacon, running 1 of these trials.
Enrollment posture brief
Registry condition atrial-fibrillation-persistent
OPEN 1 | RECR 25% | LATE 0 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Atrial Fibrillation, Persistent lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Atrial Fibrillation, Persistent on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Atrial Fibrillation, Persistent is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Optimal Pacing Rate for Cardiac Resynchronization Therapy
Medstar Health Research Institute
NCT06445439
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
Cortex
NCT05883631
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Abbott Medical Devices
NCT06172699
AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
Ablacon
NCT05481359
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Atrial Fibrillation, Persistent records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Atrial Fibrillation, Persistent trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Atrial Fibrillation, Persistent page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Atrial Fibrillation, Persistent trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Ablacon sponsors the most Atrial Fibrillation, Persistent trials on record, review their full trial history before evaluating a specific study. See Ablacon's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Atrial Fibrillation, Persistent condition card totals 4 registered trials; most-linked intervention Electrographic Flow™ (EGF) mapping and ablation; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.